U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07495059) titled 'Adaptation and Implementation of an Evidence-based Approach to Advance HIV Prevention and Care' on March 17.
Brief Summary: Transgender women in the intervention condition will attend TransAction individual risk reduction sessions; skill building and open group support sessions, and social events between baseline and 3-month assessment. Transgender women participants in the control condition will be invited to social events only.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
HIV (Human Immunodeficiency Virus)
Continuum of Care
Stigma
Intervention:
BEHAVIORAL: TransAction
Immediately following the baseline,...